Showing 5221-5230 of 19420 results for "".
From Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity
https://reachmd.com/programs/clinicians-roundtable/roseburia-hominis-obesity-treatment/39658/A new preclinical study investigated whether Roseburia hominis, a gut microbe often depleted in individuals with obesity, could play a direct role in regulating metabolism. Learn more as Dr. Hallie Blevins explores these findings and their potential implications for future treatment of obesity anModern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
https://reachmd.com/programs/project-oncology/survival-trends-breast-cancer-brain-metastases/48769/How are patients with breast cancer brain metastases faring in the modern treatment era? In this AudioAbstract, Ryan Quigley shares findings from a 25-year review of 507 patients at UCSF, providing new insights into how survival outcomes have shifted across subtypes and which treatments are drivingRethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
https://reachmd.com/programs/living-rheum/sle-treatment-approvals-novel-targets/39846/Systemic lupus erythematosus (SLE) treatment is undergoing a transformative shift from broad immunosuppression to targeted, precision-based approaches. Dr. Marc Scherlinger joins Dr. Steve Jackson to provide a timely update on recent breakthroughs, including monoclonal antibodies, JAK and BTK inhibiExploring Patient Perspectives on Genetic Testing for ATTR-CM
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/exploring-patient-perspectives-on-genetic-testing-for-attr-cm/39317/Genetic testing is a very valuable tool in managing transthyretin amyloid cardiomyopathy (ATTR-CM), but many patients face emotional, educational, and systemic barriers throughout. To learn more about the patient perspective of this process, researchers conducted interviews with ATTR-CM patients andOptimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
https://reachmd.com/programs/neurofrontiers/optimizing-generalized-myasthenia-gravis-care-through-patient-centered-choices/32860/Choosing the most appropriate treatment for generalized myasthenia gravis (gMG) involves more than managing visible symptoms. Many patients adapt to their limitations, making it essential to use structured tools that reveal the true impact on their daily life. Hear Dr. Sheetal Shroff, who spoke withRising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
https://reachmd.com/programs/clinicians-roundtable/rising-stimulant-use-among-patients-with-hiv-what-5-years-of-clinic-data-reveal/32827/At Alabama’s only integrated infectious diseases and substance use clinic, clinicians are seeing a sharp rise in stimulant use among patients with opioid use disorder and HIV. That’s why they conducted a five-year retrospective study analyzing how comorbid stimulant use impacts clinical outcomes. WhNavigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
https://reachmd.com/programs/neurofrontiers/navigating-ms-diagnosis-in-older-adults-distinguishing-comorbidities-and-mimics/32823/Diagnosing multiple sclerosis (MS) in older patients presents unique challenges, especially as age-related comorbidities and common neurological findings often mimic MS. Hear from Dr. Le Hua as she highlights the importance of thorough clinical history, cautious interpretation of imaging, and the roTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
https://reachmd.com/programs/heart-matters/triglycerides-and-residual-risk-in-secondary-cardiovascular-prevention-lessons-from-ucc-smart/37596/Even with LDL cholesterol under control, cardiovascular risk often remains. In this AudioAbstract, ReachMD's Ryan Quigley shares new insights from the UCC-SMART cohort, including how elevated triglycerides can independently predict recurrent events and mortality in patients with established cardiovaPredicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
https://reachmd.com/programs/project-oncology/predicting-hydroxyurea-resistance-in-polycythemia-vera-with-machine-learning/37210/Early resistance to hydroxyurea in patients with polycythemia vera (PV) is associated with higher risks of thromboembolic complications, disease progression, and mortality. The PV-AIM study applied machine learning to real-world data and identified simple lab-based predictors that stratify patientsBlood-Based Screening for Colorectal Cancer: Benefits and Limitations
https://reachmd.com/programs/clinicians-roundtable/blood-based-screening-for-colorectal-cancer-benefits-and-limitations/36622/Despite available options like stool-based testing and colonoscopy, colorectal cancer screening rates remain low. Blood-based testing, however, has the potential to improve adherence by offering a convenient alternative. Join Dr. Aasma Shaukat as she discusses the clinical performance of blood-based